Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Novartis Woos Payers With Data Showing Entresto Earns Its Keep

Nov 16 2016

• By Emily Hayes

Related Content

Novartis Chief: Good Things Come To Those Who Wait

Oct 26 2016

Amgen’s Biggest Seller Enbrel Hit By Pricing Pressures, Competition

Oct 28 2016

Amgen, Cytokinetics Checked With Payers Before Taking Omecamtiv Into Phase III

Sep 02 2016

Entresto US Sales Barriers Set To Be Removed By Strong Guidance

May 23 2016

Aetna: Entresto’s Label Enabled Outcome-Based Risk Share

Jun 29 2016

Novartis Accentuates The Positives Of Heart Failure Drug <em>Entresto </em>At ACC

Apr 11 2016

Related Companies

Novartis AG

Cigna Corp.

Humana Inc.

Amgen, Inc.

Cytokinetics, Inc.

Additional Topics

Clinical Trials Research & Development Cardiovascular BioPharmaceutical

More from Cardiovascular

More from Therapy Areas

Twitter feed RSS feed RSS feed

About UsOpens in new window
Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us
Customer Service
Subscribe
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window